Cargando…
Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light
BACKGROUND: Monkeypox virus has recently emerged from endemic foci in Africa and, since October 20, 2022, more than 73,000 human infections have been reported by the CDC from over 100 countries that historically have not reported monkeypox cases. The detection of virus in skin lesions, blood, semen,...
Autores principales: | Ragan, Izabela K., Hartson, Lindsay M., Sullivan, Elizabeth J., Bowen, Richard A., Goodrich, Raymond P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857991/ https://www.ncbi.nlm.nih.gov/pubmed/36662705 http://dx.doi.org/10.1371/journal.pone.0278862 |
Ejemplares similares
-
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light
por: Ragan, Izabela, et al.
Publicado: (2020) -
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies
por: Cardoso, Marcia, et al.
Publicado: (2023) -
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology
por: Yonemura, Susan, et al.
Publicado: (2021) -
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment
por: Keil, Shawn D., et al.
Publicado: (2020) -
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage
por: Owusu-Ofori, Shirley, et al.
Publicado: (2015)